Predictive and Causal Analysis of No-Shows for Medical Exams During COVID-19: A Case Study of Breast Imaging in a Nationwide Israeli Health Organization.


Journal

AMIA ... Annual Symposium proceedings. AMIA Symposium
ISSN: 1942-597X
Titre abrégé: AMIA Annu Symp Proc
Pays: United States
ID NLM: 101209213

Informations de publication

Date de publication:
2021
Historique:
entrez: 21 3 2022
pubmed: 22 3 2022
medline: 26 3 2022
Statut: epublish

Résumé

"No-shows", defined as missed appointments or late cancellations, is a central problem in healthcare systems. It has appeared to intensify during the COVID-19 pandemic and the nonpharmaceutical interventions, such as closures, taken to slow its spread. No-shows interfere with patients' continuous care, lead to inefficient utilization of medical resources, and increase healthcare costs. We present a comprehensive analysis of no-shows for breast imaging appointments made during 2020 in a large medical network in Israel. We applied advanced machine learning methods to provide insights into novel and known predictors. Additionally, we employed causal inference methodology to infer the effect of closures on no-shows, after accounting for confounding biases, and demonstrate the superiority of adversarial balancing over inverse probability weighting in correcting these biases. Our results imply that a patient's perceived risk of cancer and the COVID-19 time-based factors are major predictors. Further, we reveal that closures impact patients over 60, but not patients undergoing advanced diagnostic examinations.

Identifiants

pubmed: 35308922
pii: 3576960
pmc: PMC8861766

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

930-939

Informations de copyright

©2021 AMIA - All rights reserved.

Références

Nat Mach Intell. 2020 Jan;2(1):56-67
pubmed: 32607472
Clin Imaging. 2021 Aug;76:65-69
pubmed: 33567344
Entropy (Basel). 2020 Jun 17;22(6):
pubmed: 33286447
Epidemics. 2019 Dec;29:100356
pubmed: 31624039
Health Policy. 2018 Apr;122(4):412-421
pubmed: 29482948
J Am Coll Radiol. 2020 Jul;17(7):855-864
pubmed: 32505562
Multivariate Behav Res. 2011 May;46(3):399-424
pubmed: 21818162
J Am Coll Radiol. 2017 Oct;14(10):1303-1309
pubmed: 28673777
Biometrics. 1988 Sep;44(3):837-45
pubmed: 3203132
Stud Health Technol Inform. 2017;235:181-185
pubmed: 28423779
Radiol Clin North Am. 2021 Jan;59(1):1-11
pubmed: 33222992
Sci Data. 2021 Mar 25;8(1):94
pubmed: 33767205

Auteurs

Michal Ozery-Flato (M)

IBM Research-Haifa, Haifa, Israel.

Ora Pinchasov (O)

Assuta Medical Centers, Tel Aviv, Israel.

Miel Dabush-Kasa (M)

Assuta Medical Centers, Tel Aviv, Israel.

Efrat Hexter (E)

IBM Research-Haifa, Haifa, Israel.

Gabriel Chodick (G)

Maccabi Healthcare Services, Tel Aviv, Israel.
Tel Aviv University, Tel Aviv, Israel.

Michal Guindy (M)

Assuta Medical Centers, Tel Aviv, Israel.
Ben Gurion University of the Negev, Beer Sheva, Israel.

Michal Rosen-Zvi (M)

IBM Research-Haifa, Haifa, Israel.
The Hebrew University, Jerusalem, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH